Following the news of BioNTech’s planned purchase, CureVac N.V. (NASDAQ: CVAC) had a significant spike in trading during the previous session. The revelation that BioNTech
CureVac N.V. (NASDAQ:CVAC) shares fell to a low of $117.00 before closing at $125.00. Intraday shares traded counted 1.75 million, which was -75.14% lower than
CureVac N.V. (NASDAQ:CVAC) shares fell to a low of $110.81 before closing at $111.48. Intraday shares traded counted 0.48 million, which was 53.55% higher than
CureVac N.V. (NASDAQ:CVAC) previous close was $115.67 while the outstanding shares total 177.97M. CVAC’s shares traded lower over the last trading session, losing -1.14% on
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne